Max Søgaard

Expression

Max Søgaard brings over 23 years of scientific research and process development experience, including a decade at ExpreS2ion Biotechnologies where he advanced from Senior Scientist to Senior Vice President. He played a pivotal role in innovating vaccine manufacturing processes, collaborating with Contract Manufacturing Organizations, refining processes, and contributing to regulatory efforts. Previously, he spent 13 years in academic research, focusing on infectious disease applications in structural biology and molecular biophysics. As the head of internal R&D, Max leads ExpreS2ion's platform and vaccine pipeline development.